L. Pronk - Concepedia

Author

L. Pronk

Rotterdam University of Applied Sciences

Also Known As

L C Pronk, L Pronk, L. C. Pronk, L. Pronk, L.C. Pronk, LC Pronk

Publications

676

Citations

H-Index

Concepts

All Affiliations

Rotterdam University of Applied Sciences Roche (Switzerland)

About

L. Pronk is an author at Rotterdam University of Applied Sciences specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	122
2	Health Sciences	1	1	29
3	Immunology	1	1	29
4	Neurology	1	1	73
5	Pathology	1	1	20

L. Pronk

Publications

622

Citations

H-Index

Page 1

	Year	Citations
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy Martin J. van den Bent, J. Kros, J.J. Heimans, Neurology	1998	202
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours L. Pronk, P. Vasey, Alex Sparreboom, British Journal of Cancer	2000	96
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin PHE Hilkens, L. Pronk, Jaap Verweij, British Journal of Cancer Peripheral NeuropathyMedicineMetronomic TherapyNeuropathic PainNeuropharmacology	1997	73
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours Gerhardt Attard, Jos Kitzen, Sarah P. Blagden, British Journal of Cancer	2007	71
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors. L. Pronk, Jan H.M. Schellens, A.S.T. Planting, Journal of Clinical Oncology	1997	66
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine L. Pronk, André Planting, R. Oosterom, European Journal of Cancer Platelet CountsThrombosisThrombopoiesisBlood PlateletMedicine	1994	29
Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel L. Pronk, PHE Hilkens, Martin J. van den Bent, Anti-Cancer Drugs	1998	22
Pharmacokinetics of Ifosfamide Are Changed by Combination With Docetaxel D. Schrijvers, L. Pronk, Martin Highley, American Journal of Clinical Oncology	2000	21
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours L. Pronk, D. Schrijvers, JHM Schellens, British Journal of Cancer MedicinePathologyAdvanced Solid TumoursPharmacotherapyMolecular Oncology	1998	20
Phase II Study of Weekly Dose-intensified Cisplatin Chemotherapy with Oral Etoposide in Recurrent Glioma Martin J. van den Bent, L. Pronk, P.A.E. Sillevis Smitt, Journal of Neuro-Oncology	1999	12

Page 1